US Stock MarketDetailed Quotes

OTLK Outlook Therapeutics

Watchlist
  • 5.250
  • +0.030+0.57%
Close Oct 2 16:00 ET
  • 5.250
  • 0.0000.00%
Post 16:02 ET
124.19MMarket Cap-891P/E (TTM)

Outlook Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Outlook Therapeutics Q3 2024 Earnings Date

Currency：USDAug 14, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-1.03
-0.89
+0.14
Beat Est.
+35.88%
+44.72%
+13.25%
Analyst Rating
Strong Buy

Sep 30, 2024

Outlook Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Aug 14, 20242024/Q30.000 / 0.000--
May 16, 20242024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Aug 14, 20242024/Q30.000 / 0.000--
May 16, 20242024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Outlook Therapeutics Earnings Reports

  • Outlook Therapeutics | 10-Q: Q3 2024 Earnings Report

    Aug 14 16:21 ET

  • Outlook Therapeutics | 10-Q: Q2 2024 Earnings Report

    May 15 17:22 ET

  • Outlook Therapeutics | 10-Q: Q1 2024 Earnings Report

    Feb 14 17:17 ET

  • Outlook Therapeutics | 10-K/A: Annual report (Amendment)

    Jan 24 17:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data